Disintegration and Dissolution Testing of Green Tea Dietary Supplements: Application and Evaluation of United States Pharmacopeial Standards

2020 ◽  
Vol 109 (6) ◽  
pp. 1933-1942
Author(s):  
Pavel A. Gusev ◽  
Karen W. Andrews ◽  
Sushma Savarala ◽  
Phuong-Tan Tey ◽  
Fei Han ◽  
...  
Author(s):  
David J. Weiss ◽  
Sarah A. Gehrke ◽  
Pengxin Liu ◽  
Randy J. Robinson

2016 ◽  
Vol 11 (5) ◽  
pp. 1934578X1601100
Author(s):  
John M. T. French ◽  
Matthew D. King ◽  
Owen M. McDougal

Current United States regulatory policies allow for the addition of pharmacologically active substances in dietary supplements if derived from a botanical source. The inclusion of certain nootropic drugs, such as vinpocetine, in dietary supplements has recently come under scrutiny due to the lack of defined dosage parameters and yet unproven short- and long-term benefits and risks to human health. This study quantified the concentration of vinpocetine in several commercially available dietary supplements and found that a highly variable range of 0.6–5.1 mg/serving was present across the tested products, with most products providing no specification of vinpocetine concentrations.


2011 ◽  
Vol 94 (2) ◽  
pp. 487-497 ◽  
Author(s):  
Jianghao Sun ◽  
Pei Chen ◽  
Long-Ze Lin ◽  
James M Harnly

Abstract Green tea-based dietary supplements (GTDSs) have gained popularity in the U.S. market in recent years. This study evaluated the phytochemical composition difference of GTDS in comparison with green tea leaves using an HPLC/MS fingerprinting technique coupled with chemometric analysis. Five components that are most responsible for class separation among samples were identified as (-) epicatechin gallate, strictinin, trigalloylglucose, quercetin-3-O-glucosylrhamnosylglucoside, and kaempferol-3-O-galactosyl-rhamnosylglucoside, according to the accurate mass measurements and MS/MS data. The similarity coefficients between the GTDSs in solid form with green tea were 0.55 to 0.91, while for the GTDSs in liquid form they were 0.12 to 0.89, which suggested that chemical composition variance across the GTDSs was significant. Flavonol aglycone concentrations were higher in GTDSs than in tea leaves, indicating the degradation of flavonol glycosides or the oxidation of catechin during the manufacturing and storage processes. In some GTDS samples, compounds were identified that were on the label. The results demonstrate the urgency of QC for GTDS products.


2020 ◽  
Vol 4 (Supplement_2) ◽  
pp. 1375-1375
Author(s):  
Karen Andrews ◽  
Pavel Gusev ◽  
Phuong-Tan Tey ◽  
Sushma Savarala ◽  
Laura Oh ◽  
...  

Abstract Objectives Multi-ingredient dietary supplements (DSs) containing green tea (GT) were analyzed for their phytochemical content (seven catechins and caffeine) as part of a Dietary Supplement Ingredient Database project. The label information required by FDA is the weight of the GT extract or leaf powder, unless it is part of a proprietary blend (only the blend weight needed). Any information about the concentration of GT phytochemicals is voluntary. We assessed the accuracy of the mandatory and voluntary portions of labels and the effect of proprietary blends on the phytochemical content. Methods Two lots of 37 GT DSs, estimated to contain ≥40 mg/serving of GT, were purchased in a variety of market channels. Samples were sent for analysis to two experienced laboratories. Means and standard errors for the analytically measured content of epigallocatechin gallate (EGCG; the most prevalent catechin), the summed content of the catechins (total catechins, TC), and caffeine were derived for each DS and compared to label information. Results The measured content of EGCG, TC, and caffeine showed wide ranges (0 (not detected) - 442, 0–711, and 0–982 mg/day, respectively). DSs with concentration claims for EGCG and caffeine (32% and 43%, respectively) had higher content per serving compared to DSs without such information (P < 0.05). Most DSs with voluntary claims for EGCG, TC or caffeine content (74%) had actual content within ± 20% of the labels. The catechin content was not significantly different in DSs with GT amounts listed on the label (n = 20) compared with DSs listing GT as part of a proprietary blend (n = 17). However, DSs with GT in a blend had significantly more caffeine than those with a label claim for GT amount (means (SE) per day 197 (63) vs. 49 (18), respectively; P = 0.037). Conclusions The actual content of GT constituents such as EGCG, TC and caffeine in multi-ingredient GT DSs varied depending on the labeling formats. DSs with a voluntary label claim for EGCG had significantly higher EGCG content than those with only the required claims. DSs with GT listed as a part of a blend had significantly higher levels of caffeine than products with labeled GT amounts. More complete label information would be beneficial both for consumers and for researchers who track phytochemical intakes and their associations with health outcomes. Funding Sources NIH/ODS and USDA/ARS.


2019 ◽  
Vol 3 (6) ◽  
pp. 792-794 ◽  
Author(s):  
Victor Navarro ◽  
Bharathi Avula ◽  
Ikhlas Khan ◽  
Manisha Verma ◽  
Leonard Seeff ◽  
...  

Genome ◽  
2014 ◽  
Vol 57 (9) ◽  
pp. 513-516 ◽  
Author(s):  
Damon P. Little

Ginkgo biloba L. (known as ginkgo or maidenhair tree) is a phylogenetically isolated, charismatic, gymnosperm tree. Herbal dietary supplements, prepared from G. biloba leaves, are consumed to boost cognitive capacity via improved blood perfusion and mitochondrial function. A novel DNA mini-barcode assay was designed and validated for the authentication of G. biloba in herbal dietary supplements (n = 22; sensitivity = 1.00, 95% CI = 0.59–1.00; specificity = 1.00, 95% CI = 0.64–1.00). This assay was further used to estimate the frequency of mislabeled ginkgo herbal dietary supplements on the market in the United States of America: DNA amenable to PCR could not be extracted from three (7.5%) of the 40 supplements sampled, 31 of 37 (83.8%) assayable supplements contained identifiable G. biloba DNA, and six supplements (16.2%) contained fillers without any detectable G. biloba DNA. It is hoped that this assay will be used by supplement manufacturers to ensure that their supplements contain G. biloba.


2016 ◽  
Vol 26 (2) ◽  
pp. 123-127 ◽  
Author(s):  
Sally K. Guthrie ◽  
Steven R. Erickson

The use of dietary supplements was compared between a cohort of committed exercisers, U.S. Masters Swimming (USMS) members (n = 1,042), and the general U.S. population, exemplified by respondents to the National Health and Nutrition Examination Survey (NHANES) from 2009 to 2010 (n = 6,209). USMS swimmers were significantly more likely to take dietary supplements (62%) than the general U.S. adult population, as represented by the NHANES population (37%). Those taking dietary supplements were older, more likely to be female and Caucasian, and more highly educated and affluent than those not taking supplements (p < .001 for all). When adjusted for age, race, gender, annual income, and education, masters swimmers were still more likely (p < .001) to use dietary supplements than the NHANES cohort. In addition, masters swimmers were significantly more likely (p < .001) to use either creatine or dehydroepiandrosterone or testosterone than those in the NHANES cohort.


Sign in / Sign up

Export Citation Format

Share Document